PUXEDDU, ERMANNO
 Distribuzione geografica
Continente #
NA - Nord America 14.576
AS - Asia 2.000
EU - Europa 1.785
SA - Sud America 282
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 29
OC - Oceania 10
Totale 18.910
Nazione #
US - Stati Uniti d'America 14.493
SG - Singapore 844
IT - Italia 409
CN - Cina 344
KR - Corea 240
FR - Francia 229
BR - Brasile 222
DE - Germania 212
RU - Federazione Russa 199
HK - Hong Kong 163
IE - Irlanda 161
VN - Vietnam 159
UA - Ucraina 143
PL - Polonia 129
GB - Regno Unito 108
SE - Svezia 56
IN - India 50
JP - Giappone 47
FI - Finlandia 43
BD - Bangladesh 41
CA - Canada 40
NL - Olanda 30
AR - Argentina 23
MX - Messico 22
BE - Belgio 16
ID - Indonesia 12
ES - Italia 11
MY - Malesia 11
TW - Taiwan 11
TR - Turchia 10
AU - Australia 9
IQ - Iraq 9
JM - Giamaica 9
CO - Colombia 8
RO - Romania 8
CL - Cile 7
EC - Ecuador 7
KG - Kirghizistan 7
PK - Pakistan 7
SA - Arabia Saudita 7
AT - Austria 6
EG - Egitto 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
PY - Paraguay 5
TH - Thailandia 5
VE - Venezuela 5
ZA - Sudafrica 5
CR - Costa Rica 4
HU - Ungheria 4
MA - Marocco 4
NG - Nigeria 4
PE - Perù 4
PH - Filippine 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GR - Grecia 3
IL - Israele 3
RS - Serbia 3
BH - Bahrain 2
CH - Svizzera 2
GA - Gabon 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GN - Guinea 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
Totale 18.690
Città #
Woodbridge 3.480
Wilmington 3.462
Houston 3.407
Fairfield 500
Singapore 471
Ann Arbor 321
Ashburn 305
San Jose 291
Chandler 288
Seattle 221
Cambridge 170
Hong Kong 159
Beijing 145
Council Bluffs 128
Dublin 128
Kraków 119
Medford 104
Jacksonville 103
Rome 98
New York 94
The Dalles 77
Santa Clara 76
Los Angeles 70
Dearborn 69
Lawrence 47
Lauterbourg 45
Dallas 42
Tokyo 40
Ho Chi Minh City 38
Menlo Park 32
Moscow 32
Hanoi 31
Monte Vista 29
Milan 25
San Diego 24
Redwood City 23
Buffalo 22
São Paulo 19
Palo Alto 18
Naples 17
Brussels 16
Chicago 16
Phoenix 16
Helsinki 15
Orem 15
Colorado Springs 13
Redondo Beach 13
Zhengzhou 13
Chennai 12
Verona 12
Denver 11
Guangzhou 11
London 11
Nuremberg 11
Rio de Janeiro 11
Seoul 11
Stockholm 11
Jakarta 10
Manchester 10
Nanjing 10
Boardman 9
Brooklyn 9
Frankfurt am Main 9
Munich 9
Atlanta 8
Columbus 8
Norwalk 8
Kingston 7
Liverpool 7
Miami 7
New Delhi 7
Philadelphia 7
Raleigh 7
San Francisco 7
Warsaw 7
Wuhan 7
Amsterdam 6
Baghdad 6
Genoa 6
Istanbul 6
Mexico City 6
Mountain View 6
North Bergen 6
Shanghai 6
Belo Horizonte 5
Biberach an der Riss 5
Boston 5
Columbia 5
Detroit 5
Haiphong 5
Hefei 5
Johannesburg 5
Kunming 5
Montreal 5
Mumbai 5
Mülheim 5
Palermo 5
Pescara 5
Queens 5
San Antonio 5
Totale 15.269
Nome #
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy 804
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 520
Interaction between corticosteroids and muscarinic antagonists in human airways 508
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 506
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 489
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network 488
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. 487
Airflow obstruction: Is it asthma or is it COPD? 486
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 485
Optimizing drug delivery in COPD: The role of inhaler devices 484
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 481
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 469
Acute COPD exacerbation: 3 T MRI evaluation of pulmonary regional perfusion--preliminary experience. 467
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 462
The prevalence of asthma and COPD in Italy: a practice-based study 448
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 448
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 441
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 436
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? 436
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD 435
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 433
Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. 424
Iron laden macrophages in idiopathic pulmonary fibrosis: The telltale of occult alveolar hemorrhage? 424
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 424
Adherence to COPD treatment: Myth and reality 419
Impact of pulmonary vascular volume on mortality in IPF: Is it time to reconsider the role of vasculature in disease pathogenesis and progression? 413
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis 404
Human embryonic stem cells recover in vivo acute lung inflammation bleomycin-induced 397
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 396
Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects? 378
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine 377
Structured multidisciplinary discussion of HRCT scans for IPF/UIP diagnosis may result in indefinite outcomes 374
Dual bronchodilation and exacerbations of COPD 364
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 353
Human embryonic stem cells recover in vivo acute lung inflammation bleomycin-induced 346
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine 261
Olodaterol + tiotropium bromide for the treatment of COPD 247
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 246
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 217
A potential role of triple therapy for asthma patients 191
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 191
Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis 187
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations 184
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers 164
Does bronchoscopy help the diagnosis in COVID-19 infection? 150
CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease 139
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 128
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review 93
Experimental glucocorticoid receptor agonists for the treatment of asthma: a systematic review 92
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients 91
Are there pulmonary sequelae in patients recovering from COVID-19? 82
Indacaterol/Glycopyrronium Combination for COPD 79
Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation 76
Lung involvement in psoriatic arthritis patients: cross-sectional study on prevalence, clinical characteristics, and risk factors of a neglected comorbidity 67
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 67
Synergy across the drugs approved for the treatment of asthma 63
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 55
Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A 37
Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity 36
Spontaneous Ventilation Thoracoscopic Lung Biopsy in Undetermined Interstitial Lung Disease: Systematic Review and Meta-Analysis 36
Evaluation of high flow nasal cannulae during endobronchial ultrasound bronchoscopy (EBUS) in high anaesthetic risk patients: a monocentric prospective study 22
null 3
Totale 18.910
Categoria #
all - tutte 45.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022523 0 0 18 31 25 52 71 28 35 76 52 135
2022/2023691 77 76 22 79 79 144 59 40 58 15 24 18
2023/2024317 46 17 48 9 16 63 18 15 8 16 13 48
2024/20251.365 44 308 135 67 44 92 70 133 143 139 90 100
2025/20262.341 181 131 227 196 206 71 315 251 319 185 168 91
2026/2027380 124 141 115 0 0 0 0 0 0 0 0 0
Totale 18.910